✉ Newsletter
🌐 English

NVision Quantum

NVision Quantum develops molecular quantum systems for quantum computing and quantum-enhanced MRI using quantum spin control in organic molecules.

Category
Quantum sensing, Photonic, Other hardware
Technology
Quantum spin control in organic molecules; molecular quantum nodes with photonic-chip interfaces for computing, and quantum-enhanced MRI for sensing.
Headquarters
Ulm, Germany
Founded
2016
Ownership
Private company
Products and platforms
PIQC, POLARIS
Key people
Sella Brosh, Co-founder and Chief Executive Officer
Ilai Schwartz, Chief Technology Officer
Alex Retzker, Scientific co-founder
Martin B. Plenio, Founding Director of the Center for Quantum BioSciences at Ulm University; presented by NVision as part of the founding team
Website
nvision-quantum.com

NVision Quantum says it engineers the quantum properties of organic molecules to build systems for both quantum computing and quantum-enhanced sensing. Its approach centers on quantum spin control in organic molecules, with a stated focus on healthcare applications and on translating quantum technologies into practical tools for medicine and science.

The company presents two named platforms. PIQC is described as a quantum computing platform based on molecular quantum nodes integrated with photonic chips. POLARIS is described as a quantum-enhanced MRI product that increases the magnetic signal of engineered sugar molecules by more than 10,000 times to support real-time imaging of disease metabolism. NVision also says POLARIS is already being deployed to leading research centers globally, while its broader strategy links quantum computing and sensing under a shared molecular technology base.

Sources

Facts on this page come from the sources below, retrieved by DesignQuantum.

  1. Home | NVision nvision-quantum.com
  2. About | NVision nvision-quantum.com
  3. A single-molecule spin–photon interface (Nature, 2026; author affiliation NVision Quantum Technologies, Ulm, Germany) nature.com

Last verified: October 28, 2026

← Back to the directory